Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Adjunctive measures for prevention of surgical site infection in adults

Deverick J Anderson, MD, MPH
Daniel J Sexton, MD
Section Editor
Anthony Harris, MD, MPH
Deputy Editors
Elinor L Baron, MD, DTMH
Kathryn A Collins, MD, PhD, FACS


Surgical site infections (SSIs) are a common cause of healthcare-associated infection. The United States Centers for Disease Control and Prevention (CDC) has developed criteria that define SSI as infection related to an operative procedure that occurs at or near the surgical incision within 30 days of the procedure or within one year if an implant is left in place [1-3]. SSIs are often localized to the incision site but can also extend into deeper adjacent structures. (See "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Definitions'.)

Among surgical patients, SSIs are the most common nosocomial infection, accounting for 38 percent of nosocomial infections. It is estimated that SSIs develop in 2 to 5 percent of the more than 30 million patients undergoing surgical procedures each year (ie, 1 in 24 patients who undergo inpatient surgery in the United States has a postoperative SSI) [1,4].

The Institute for Healthcare Improvement and the Surgical Care Improvement Project have promoted a number of interventions to improve patient care and prevent avoidable deaths [5]. These include several interventions for reducing the incidence of SSIs discussed in the following sections. In one report, hospitals that instituted programs for appropriate use of antibiotics, approach to hair removal, glucose management, and thermoregulation reported a mean 27 percent reduction in SSI rates over one year (from 2.3 to 1.7 percent) [6]. In another study including more than 400,000 surgical patients, those who received at least two of the above measures had lower rates of SSI (adjusted odds ratio [aOR] 0.85, 95% CI 0.74-0.95) [7].

Antimicrobial prophylaxis is an important intervention for prevention of SSI; it is discussed in detail separately. Adjunctive measures for prevention of SSI will be reviewed here. (See "Antimicrobial prophylaxis for prevention of surgical site infection in adults".)


The most important factors in the prevention of surgical site infection (SSI) are careful attention to operative technique and timely administration of effective preoperative antibiotics.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Jun 15, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Consensus paper on the surveillance of surgical wound infections. The Society for Hospital Epidemiology of America; The Association for Practitioners in Infection Control; The Centers for Disease Control; The Surgical Infection Society. Infect Control Hosp Epidemiol 1992; 13:599.
  2. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20:271.
  3. Draft guideline for the prevention of surgical site infection, 1998--CDC. Notice. Fed Regist 1998; 63:33168.
  4. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606.
  5. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43:322.
  6. Dellinger EP, Hausmann SM, Bratzler DW, et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 2005; 190:9.
  7. Stulberg JJ, Delaney CP, Neuhauser DV, et al. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010; 303:2479.
  8. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14:73.
  9. Fan CJ, Pawlik TM, Daniels T, et al. Association of Safety Culture with Surgical Site Infection Outcomes. J Am Coll Surg 2016; 222:122.
  10. Haley RW, Quade D, Freeman HE, Bennett JV. The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design. Am J Epidemiol 1980; 111:472.
  11. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182.
  12. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250.
  13. Condon RE, Schulte WJ, Malangoni MA, Anderson-Teschendorf MJ. Effectiveness of a surgical wound surveillance program. Arch Surg 1983; 118:303.
  14. Olson MM, Lee JT Jr. Continuous, 10-year wound infection surveillance. Results, advantages, and unanswered questions. Arch Surg 1990; 125:794.
  15. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27:97.
  16. Avato JL, Lai KK. Impact of postdischarge surveillance on surgical-site infection rates for coronary artery bypass procedures. Infect Control Hosp Epidemiol 2002; 23:364.
  17. Sands K, Vineyard G, Livingston J, et al. Efficient identification of postdischarge surgical site infections: use of automated pharmacy dispensing information, administrative data, and medical record information. J Infect Dis 1999; 179:434.
  18. Sands KE, Yokoe DS, Hooper DC, et al. Detection of postoperative surgical-site infections: comparison of health plan-based surveillance with hospital-based programs. Infect Control Hosp Epidemiol 2003; 24:741.
  19. Petherick ES, Dalton JE, Moore PJ, Cullum N. Methods for identifying surgical wound infection after discharge from hospital: a systematic review. BMC Infect Dis 2006; 6:170.
  20. Anderson DJ, Chen LF, Sexton DJ, Kaye KS. Complex surgical site infections and the devilish details of risk adjustment: important implications for public reporting. Infect Control Hosp Epidemiol 2008; 29:941.
  21. Tanner J, Dumville JC, Norman G, Fortnam M. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 2016; :CD004288.
  22. Parienti JJ, Thibon P, Heller R, et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA 2002; 288:722.
  23. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002; 23:S3.
  24. Tanner J. Surgical hand antisepsis: the evidence. J Perioper Pract 2008; 18:330.
  25. Vincent M, Edwards P. Disposable surgical face masks for preventing surgical wound infection in clean surgery. Cochrane Database Syst Rev 2016; 4:CD002929.
  26. Belkin NL. The evolution of the surgical mask: filtering efficiency versus effectiveness. Infect Control Hosp Epidemiol 1997; 18:49.
  27. Ward WG Sr, Cooper JM, Lippert D, et al. Glove and gown effects on intraoperative bacterial contamination. Ann Surg 2014; 259:591.
  28. Brough SJ, Hunt TM, Barrie WW. Surgical glove perforations. Br J Surg 1988; 75:317.
  29. Hübner NO, Goerdt AM, Stanislawski N, et al. Bacterial migration through punctured surgical gloves under real surgical conditions. BMC Infect Dis 2010; 10:192.
  30. Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:605.
  31. Selwyn S, Ellis H. Skin bacteria and skin disinfection reconsidered. Br Med J 1972; 1:136.
  32. Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med 2010; 362:18.
  33. Dumville JC, McFarlane E, Edwards P, et al. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 2015; :CD003949.
  34. Tuuli MG, Liu J, Stout MJ, et al. A Randomized Trial Comparing Skin Antiseptic Agents at Cesarean Delivery. N Engl J Med 2016; 374:647.
  35. Brown TR, Ehrlich CE, Stehman FB, et al. A clinical evaluation of chlorhexidine gluconate spray as compared with iodophor scrub for preoperative skin preparation. Surg Gynecol Obstet 1984; 158:363.
  36. Stonecypher K. Going around in circles: is this the best practice for preparing the skin? Crit Care Nurs Q 2009; 32:94.
  37. Zhao X, Chen J, Fang XQ, Fan SW. Surgical site marking will not affect sterility of the surgical field. Med Hypotheses 2009; 73:319.
  38. Mishriki SF, Law DJ, Jeffery PJ. Factors affecting the incidence of postoperative wound infection. J Hosp Infect 1990; 16:223.
  39. Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980; 60:27.
  40. Tanner J, Norrie P, Melen K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 2011; :CD004122.
  41. Hamilton HW, Hamilton KR, Lone FJ. Preoperative hair removal. Can J Surg 1977; 20:269.
  42. Seropian R, Reynolds BM. Wound infections after preoperative depilatory versus razor preparation. Am J Surg 1971; 121:251.
  43. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2015; :CD004985.
  44. Hebert C, Robicsek A. Decolonization therapy in infection control. Curr Opin Infect Dis 2010; 23:340.
  45. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346:1871.
  46. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362:9.
  47. Schweizer ML, Chiang HY, Septimus E, et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 2015; 313:2162.
  48. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996; 17:780.
  49. Hetem DJ, Bootsma MC, Bonten MJ. Prevention of Surgical Site Infections: Decontamination With Mupirocin Based on Preoperative Screening for Staphylococcus aureus Carriers or Universal Decontamination? Clin Infect Dis 2016; 62:631.
  50. Anderson DJ, Sexton DJ, Kanafani ZA, et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:1047.
  51. Coello R, Jiménez J, García M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13:74.
  52. Lee AS, Macedo-Vinas M, François P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011; 52:1422.
  53. Segers P, Speekenbrink RG, Ubbink DT, et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006; 296:2460.
  54. Doebbeling BN, Reagan DR, Pfaller MA, et al. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994; 154:1505.
  55. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008; :CD006216.
  56. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998; 69:412.
  57. Farr BM. Mupirocin to prevent S. aureus infections. N Engl J Med 2002; 346:1905.
  58. Suzuki Y, Kamigaki T, Fujino Y, et al. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Br J Surg 2003; 90:1072.
  59. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002; 35:353.
  60. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005; 26:916.
  61. Shrestha NK, Banbury MK, Weber M, et al. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery. Ann Thorac Surg 2006; 81:2183.
  62. Wenzel RP. Minimizing surgical-site infections. N Engl J Med 2010; 362:75.
  63. Schweizer M, Perencevich E, McDanel J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 2013; 346:f2743.
  64. Bebko SP, Green DM, Awad SS. Effect of a preoperative decontamination protocol on surgical site infections in patients undergoing elective orthopedic surgery with hardware implantation. JAMA Surg 2015; 150:390.
  65. Westberg M, Frihagen F, Brun OC, et al. Effectiveness of gentamicin-containing collagen sponges for prevention of surgical site infection after hip arthroplasty: a multicenter randomized trial. Clin Infect Dis 2015; 60:1752.
  66. Altemeier WA, Burke JF, Pruitt BA, Sandusky WR. Manual on Control of Infection in Surgical Patients, JB Lippincott, Philadelphia 1984.
  67. Bergs J, Hellings J, Cleemput I, et al. Systematic review and meta-analysis of the effect of the World Health Organization surgical safety checklist on postoperative complications. Br J Surg 2014; 101:150.
  68. Gandaglia G, Ghani KR, Sood A, et al. Effect of minimally invasive surgery on the risk for surgical site infections: results from the National Surgical Quality Improvement Program (NSQIP) Database. JAMA Surg 2014; 149:1039.
  69. Gaynes RP, Culver DH, Horan TC, et al. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001; 33 Suppl 2:S69.
  70. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334:1209.
  71. Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 2001; 358:876.
  72. Randomised trial of normothermic versus hypothermic coronary bypass surgery. The Warm Heart Investigators. Lancet 1994; 343:559.
  73. Zheng H, Barnett AG, Merollini K, et al. Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison. BMJ Open 2014; 4:e003978.
  74. Kaiser AB, Kernodle DS, Parker RA. Low-inoculum model of surgical wound infection. J Infect Dis 1992; 166:393.
  75. Lidwell OM, Lowbury EJ, Whyte W, et al. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed) 1982; 285:10.
  76. Aglietti P, Salvati EA, Wilson PD Jr, Kutner LJ. Effect of a surgical horizontal unidirectional filtered air flow unit on wound bacterial contamination and wound healing. Clin Orthop Relat Res 1974; :99.
  77. Marotte JH, Lord GA, Blanchard JP, et al. Infection rate in total hip arthroplasty as a function of air cleanliness and antibiotic prophylaxis. 10-year experience with 2,384 cementless Lord madreporic prostheses. J Arthroplasty 1987; 2:77.
  78. Lidwell OM. Clean air at operation and subsequent sepsis in the joint. Clin Orthop Relat Res 1986; :91.
  79. Persson U, Montgomery F, Carlsson A, et al. How far does prophylaxis against infection in total joint replacement offset its cost? Br Med J (Clin Res Ed) 1988; 296:99.
  80. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27:1247.
  81. Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br 2012; 94:1330.
  82. Brandt C, Hott U, Sohr D, et al. Operating room ventilation with laminar airflow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Ann Surg 2008; 248:695.
  83. Greif R, Akça O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000; 342:161.
  84. Pryor KO, Fahey TJ 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 2004; 291:79.
  85. Belda FJ, Aguilera L, García de la Asunción J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005; 294:2035.
  86. Mayzler O, Weksler N, Domchik S, et al. Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery? Minerva Anestesiol 2005; 71:21.
  87. Myles PS, Leslie K, Chan MT, et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 2007; 107:221.
  88. Meyhoff CS, Wetterslev J, Jorgensen LN, et al. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA 2009; 302:1543.
  89. Qadan M, Akça O, Mahid SS, et al. Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials. Arch Surg 2009; 144:359.
  90. Hovaguimian F, Lysakowski C, Elia N, Tramèr MR. Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary function: systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2013; 119:303.
  91. Munoz-Price LS, Sands L, Lubarsky DA. Effect of high perioperative oxygen supplementation on surgical site infections. Clin Infect Dis 2013; 57:1465.
  92. Allen DB, Maguire JJ, Mahdavian M, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997; 132:991.
  93. Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997; 132:997.
  94. Hunt TK, Linsey M, Grislis H, et al. The effect of differing ambient oxygen tensions on wound infection. Ann Surg 1975; 181:35.
  95. Hartmann M, Jönsson K, Zederfeldt B. Effect of tissue perfusion and oxygenation on accumulation of collagen in healing wounds. Randomized study in patients after major abdominal operations. Eur J Surg 1992; 158:521.
  96. Kohanski MA, Dwyer DJ, Hayete B, et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130:797.
  97. Price CI, Horton JW, Baxter CR. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics. Surgery 1994; 115:480.
  98. Stone PA, Mousa AY, Hass SM, et al. Antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary vascular surgical site infections. J Vasc Surg 2012; 55:1706.
  99. Chiu KM, Lin TY, Chu SH, Lu CW. Managing sternal osteomyelitis with antibiotic bead implantation. Asian Cardiovasc Thorac Ann 2006; 14:e41.
  100. Chang WK, Srinivasa S, MacCormick AD, Hill AG. Gentamicin-collagen implants to reduce surgical site infection: systematic review and meta-analysis of randomized trials. Ann Surg 2013; 258:59.
  101. Wood C, Phillips C. Cyanoacrylate microbial sealants for skin preparation prior to surgery. Cochrane Database Syst Rev 2016; :CD008062.
  102. Edwards JP, Ho AL, Tee MC, et al. Wound protectors reduce surgical site infection: a meta-analysis of randomized controlled trials. Ann Surg 2012; 256:53.
  103. Pinkney TD, Calvert M, Bartlett DC, et al. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). BMJ 2013; 347:f4305.
  104. Mihaljevic AL, Schirren R, Özer M, et al. Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206). Ann Surg 2014; 260:730.
  105. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311:1317.